Clinical Trial Update: A Research Study Looking Into Blood Levels of the Medicine NNC0519-0130 in the Body in Participants With Normal or Reduced Kidney Function [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study by Novo Nordisk investigates how the drug NNC0519-0130 behaves in participants with normal or reduced kidney function in the con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0519-0130

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED